Literature DB >> 22946870

Antimicrobial drug interactions in the critically ill patients.

Jose M Pereira1, Jose A Paiva.   

Abstract

Critically ill patients are typically polymedicated and therefore at a high risk for potential drug interactions. Clinical consequences of drugs interactions vary in severity from mild to lethal events. Since infection is an important issue in the Intensive Care Unit (ICU), a significant number of patients will receive an antimicrobial at some stage during their ICU admission. Therefore an adequate knowledge about possible interactions between antimicrobials and other drugs is necessary, since it may not only impact on the effectiveness of the antimicrobial but also in the incidence of drug adverse events. This review describes important drug interactions involving antimicrobials in the critically ill patient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22946870

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  8 in total

Review 1.  [Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].

Authors:  R Bellmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-03-20       Impact factor: 0.840

Review 2.  [Personalised pharmacotherapy in intensive care unit patients].

Authors:  R Bellmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-02       Impact factor: 0.840

3.  High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care.

Authors:  Jian Li; Olajide E Olaleye; Xuan Yu; Weiwei Jia; Junling Yang; Chuang Lu; Songqiao Liu; Jingjing Yu; Xiaona Duan; Yaya Wang; Kai Dong; Rongrong He; Chen Cheng; Chuan Li
Journal:  Acta Pharm Sin B       Date:  2019-06-19       Impact factor: 11.413

Review 4.  COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications.

Authors:  M Chumbita; P Puerta-Alcalde; N Garcia-Pouton; C García-Vidal
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

5.  Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines.

Authors:  Chuan Li; Wei-Wei Jia; Jun-Ling Yang; Chen Cheng; Olajide E Olaleye
Journal:  Acta Pharmacol Sin       Date:  2022-09-16       Impact factor: 7.169

Review 6.  Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.

Authors:  Fumihiro Mizokami; Tomohiro Mizuno
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 4.271

7.  Important drug classes associated with potential drug-drug interactions in critically ill patients: highlights for cardiothoracic intensivists.

Authors:  Shadi Baniasadi; Behrooz Farzanegan; Maryam Alehashem
Journal:  Ann Intensive Care       Date:  2015-11-24       Impact factor: 6.925

8.  Evaluation of potential drug-drug interactions in a pediatric population.

Authors:  Berna Terzioğlu Bebitoğlu; Elif Oğuz; Çağatay Nuhoğlu; Ayşe Ela Kurtdan Dalkılıç; Pelin Çirtlik; Fatime Temel; Ajla Hodzic
Journal:  Turk Pediatri Ars       Date:  2020-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.